SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.

Merlo A, D'Elia E, Di Odoardo L, Sciatti E, Senni M

Open source

DOI
10.1093/eurheartjsupp/suae117
Published
2025 Feb
Container
European heart journal supplements : journal of the European Society of Cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurheartjsupp/suae117,
  title = {SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.},
  author = {Merlo A and D'Elia E and Di Odoardo L and Sciatti E and Senni M},
  year = {2025},
  journal = {European heart journal supplements : journal of the European Society of Cardiology},
  doi = {10.1093/eurheartjsupp/suae117},
  url = {https://doi.org/10.1093/eurheartjsupp/suae117}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
AU  - Merlo A
AU  - D'Elia E
AU  - Di Odoardo L
AU  - Sciatti E
AU  - Senni M
PY  - 2025
JO  - European heart journal supplements : journal of the European Society of Cardiology
DO  - 10.1093/eurheartjsupp/suae117
UR  - https://doi.org/10.1093/eurheartjsupp/suae117
ER  - 

APA

A, M., E, D., L, D. O., E, S., & M, S. (2025). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.. European heart journal supplements : journal of the European Society of Cardiology. https://doi.org/10.1093/eurheartjsupp/suae117

Source records